112 related articles for article (PubMed ID: 9783330)
1. Effects of lead exposure on licking and yawning behaviour in rats.
Ghazi-Khansari M; Rezvani N; Bani-Assadi S; Zarrindast MR
Pharmacol Toxicol; 1998 Sep; 83(3):120-4. PubMed ID: 9783330
[TBL] [Abstract][Full Text] [Related]
2. Interactions of drugs acting on central dopamine receptors and cholinoceptors on yawning responses in the rat induced by apomorphine, bromocriptine or physostigmine.
Zarrindast MR; Poursoltan M
Br J Pharmacol; 1989 Apr; 96(4):843-8. PubMed ID: 2663110
[TBL] [Abstract][Full Text] [Related]
3. [Effects of bifemelane on central dopaminergic and cholinergic systems in rats].
Ushijima I; Tsutsumi C; Hara T; Soeda K; Kishimoto O; Kaneyuki H; Mizuki Y; Yamada M
Yakubutsu Seishin Kodo; 1988 Dec; 8(4):463-70. PubMed ID: 2907957
[TBL] [Abstract][Full Text] [Related]
4. Effect of acute and chronic lead exposure on apomorpine-induced sniffing in rats.
Fazli-Tabaei S; Fahim M; Zarrindast MR
Pharmacol Toxicol; 2003 Feb; 92(2):88-93. PubMed ID: 12747578
[TBL] [Abstract][Full Text] [Related]
5. Dopamine agonist-induced yawning in rats: a dopamine D3 receptor-mediated behavior.
Collins GT; Witkin JM; Newman AH; Svensson KA; Grundt P; Cao J; Woods JH
J Pharmacol Exp Ther; 2005 Jul; 314(1):310-9. PubMed ID: 15833897
[TBL] [Abstract][Full Text] [Related]
6. Behavioral effects of dilazep on cholinergic, dopaminergic, and purinergic systems in the rat.
Ushijima I; Mizuki Y; Ukita T; Kaneyuki H; Inano S; Yamada M
Pharmacol Biochem Behav; 1992 Nov; 43(3):673-6. PubMed ID: 1360158
[TBL] [Abstract][Full Text] [Related]
7. Multifocal sites of action involved in dopaminergic-cholinergic neuronal interactions in yawning.
Ushijima I; Mizuki Y; Yamada M
Psychopharmacology (Berl); 1988; 95(1):34-7. PubMed ID: 3133698
[TBL] [Abstract][Full Text] [Related]
8. [Behavioral effects of chronic apomorphine, and D-1/D-2 dopamine receptor activities in rats].
Minematsu N
Nihon Shinkei Seishin Yakurigaku Zasshi; 1995 Jun; 15(3):247-52. PubMed ID: 7584718
[TBL] [Abstract][Full Text] [Related]
9. Effects of different periods of lithium pretreatment and aminoglycoside antibiotics on apomorphine-induced yawning in rats.
Sharifzadeh M; Firooz EK; Abdollahi M
Pharmacol Toxicol; 2000 Aug; 87(2):84-8. PubMed ID: 10989946
[TBL] [Abstract][Full Text] [Related]
10. Effects of age on behavioral responses to dopamine agonists in the rat.
Ushijima I; Mizuki Y; Soeda K; Kishimoto O; Hara T; Yamada M
Eur J Pharmacol; 1987 Jun; 138(1):101-6. PubMed ID: 2887433
[TBL] [Abstract][Full Text] [Related]
11. Apomorphine produced more yawning in Sprague-Dawley rats than in F344 rats: a pharmacological study.
Tang AH; Himes CS
Eur J Pharmacol; 1995 Sep; 284(1-2):13-8. PubMed ID: 8549616
[TBL] [Abstract][Full Text] [Related]
12. Yawning induced by apomorphine, physostigmine or pilocarpine is potentiated by dihydropyridine calcium channel blockers.
Bourson A; Moser PC
Psychopharmacology (Berl); 1990; 100(2):168-72. PubMed ID: 1689500
[TBL] [Abstract][Full Text] [Related]
13. Effects of adenosine agents on apomorphine-induced yawning in rats.
Zarrindast MR; Fatehi F; Mohagheghi-Badi M
Psychopharmacology (Berl); 1995 Dec; 122(3):292-6. PubMed ID: 8748398
[TBL] [Abstract][Full Text] [Related]
14. Acute or chronic effects of cannabinoids on spontaneous or pharmacologically induced yawning in rats.
Nakamura-Palacios EM; Amodeo Bueno OF; Takahashi RN; Tufik S
Pharmacol Biochem Behav; 2002 Dec; 74(1):205-12. PubMed ID: 12376169
[TBL] [Abstract][Full Text] [Related]
15. Treatment with dexamethasone alters yawning behavior induced by cholinergic but not dopaminergic agonist.
Hipólide DC; Lobo LL; De Medeiros R; Neumann B; Tufik S
Physiol Behav; 1999 Jan 1-15; 65(4-5):829-32. PubMed ID: 10073488
[TBL] [Abstract][Full Text] [Related]
16. Behavioural evidence that different neurochemical mechanisms underly stretching-yawning and penile erection induced in male rats by SND 919, a new selective D2 dopamine receptor agonist.
Ferrari F; Pelloni F; Giuliani D
Psychopharmacology (Berl); 1993; 113(2):172-6. PubMed ID: 7855178
[TBL] [Abstract][Full Text] [Related]
17. [Age-related modification of dopaminergic-cholinergic neuronal interaction in rats].
Kishimoto O
Yakubutsu Seishin Kodo; 1988 Dec; 8(4):443-51. PubMed ID: 3250156
[TBL] [Abstract][Full Text] [Related]
18. Modification of apomorphine-, physostigmine- and pilocarpine-induced yawning after long-term treatment with neuroleptic or cholinergic agents.
Ushijima I; Noda Y; Mizuki Y; Yamada M
Arch Int Pharmacodyn Ther; 1984 Oct; 271(2):180-8. PubMed ID: 6150689
[TBL] [Abstract][Full Text] [Related]
19. Yawning induced by apomorphine, physostigmine or pilocarpine is inhibited by electroconvulsive shock (ECS).
Wielosz M; Szymczyk H
Acta Physiol Hung; 1996; 84(4):473-5. PubMed ID: 9328636
[TBL] [Abstract][Full Text] [Related]
20. Interaction of cholinergic and dopaminergic influences on yawning behavior.
Holmgren B; Urbá-Holmgren R
Acta Neurobiol Exp (Wars); 1980; 40(3):633-42. PubMed ID: 6969021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
